Clinical Trials Directory

Trials / Completed

CompletedNCT03820882

Stent Retriever for Thrombectomy Revascularisation of Large Vessel Occlusions in Acute Ischemic Stroke(Catfish)

Catfish Flow Restoration Device for Thrombectomy Revascularisation of Large Vessel Occlusions in Acute Ischemic Stroke: a Randomised, Parallel-group, Non-inferiority Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
238 (actual)
Sponsor
Ministry of Science and Technology of the People´s Republic of China · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The study is a randomized, prospective, parallel-group, multicenter, open-label, non-inferiority trial. Patients are randomized 1 : 1 to either stent retriever(Catfish) or Solitaire for endovascular therapy for acute ischemic stroke. The study aims to evaluate the benefit and safety of stent retriever(Catfish) for acute ischemic stroke therapy, as compared to Solitaire FR.

Detailed description

The main objective is to determine whether stent retriever(Catfish) will have non-inferior successful recanalization rate compared to Solitaire in patients with acute ischemic stroke caused by large vessel occlusion. The secondary objectives is to verify whether there is significant differences in time from artery puncture to successful recanalization (mTICI 2b or greater), NIHSS score at 24 hours and at 7 days or discharge if earlier, good clinical outcomes at 90 days (defined as mRS score ≤2) between stent retriever(Catfish) and Solitaire in patients with acute ischemic stroke caused by large vessel occlusion. The third objectives is to compare the rate of symptomatic intracranial hemorrhage, serious adverse event(SAE), all cause of mortality with 90 days after operation, between stent retriever (Catfish) and Solitaire in patients with acute ischemic stroke due to large vessel occlusion.

Conditions

Interventions

TypeNameDescription
DEVICECatfishPatients will be treated for mechanical recanalization with Catfish within 8 hours after stroke onset plus standard medical management.
DEVICESolitaire FRPatients will be treated for mechanical recanalization with Solitaire FR within 8 hours after stroke onset plus standard medical management.

Timeline

Start date
2019-03-03
Primary completion
2021-01-05
Completion
2021-06-05
First posted
2019-01-29
Last updated
2022-09-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03820882. Inclusion in this directory is not an endorsement.